CRT 2025
Technology and Innovation
BRS DES and DCB Technologies
Sahil A. Parikh, MD, FSCAI
Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States
Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Acotec: Grant/Research Support (Ongoing); Advanced NanoTherapies: Stock-privately held company (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Concept Medical: Grant/Research Support (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Efemoral Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Encompass vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); R3 Vascular: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Veryan Medical: Grant/Research Support (Ongoing)